OLR1 and nasopharyngeal carcinoma: (Figure 2A) Addition of LOX-1+ PMN-MDSCs from NPC survivor with CHB, resulted in significantly reduced proliferation of both CD4+ and CD8+ T cells in a dose-dependent manner.